ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer

Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism

(2016) Min Jia et al.   CANCER RESEARCH

ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

(2015) Peijing Zhang et al.   CELL CYCLE

Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome

(2015) Min Hye Jang et al.   HUMAN PATHOLOGY

Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

(2014) Antonio Díaz-López et al.   INTERNATIONAL JOURNAL OF CANCER

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1

(2014) Peijing Zhang et al.   NATURE CELL BIOLOGY

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1

(2014) Yihua Wang et al.   NATURE CELL BIOLOGY

Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity

(2013) Christine L. Chaffer et al.   CELL

δEF1 Down-Regulates ER-α Expression and Confers Tamoxifen Resistance in Breast Cancer

(2012) Shaocong Guo et al.   PLoS One

The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells

(2011) Simone Brabletz et al.   EMBO JOURNAL

Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer

(2011) Ali Aghdassi et al.   GUT

A ZEB1-HDAC pathway enters the epithelial to mesenchymal transition world in pancreatic cancer: Figure 1

(2011) Günter Schneider et al.   GUT

Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α

(2011) F Vesuna et al.   ONCOGENE

Pharmacogenetics of Endocrine Therapy for Breast Cancer

(2010) Michaela J. Higgins et al.   Annual Review of Medicine

Mechanisms of Endocrine Resistance in Breast Cancer

(2010) C. Kent Osborne et al.   Annual Review of Medicine

Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling

(2010) I. Barone et al.   CLINICAL CANCER RESEARCH

E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer

(2009) Otto Schmalhofer et al.   CANCER AND METASTASIS REVIEWS

ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers

(2009) Joeli A. Brinkman et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA